Orion Biotech Opportunities Corp. (ORIA)
Orion Biotech Opportunities Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $10.23, up 0.00% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of 11.12, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Orion Biotech Opportunities Corp. functions as a blank check company, meaning its primary goal is to undertake a business combination – such as a merger, acquisition of assets or shares, or a corporate reorganization – with one or more existing businesses. Established in 2021, the company is headquartered in New York, New York.
Orion Biotech Opportunities Corp. is most often compared with the following Financial Services names: